Drug
IV r-tPA
IV r-tPA is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (100.0%)
Trials by Status
completed133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
NCT01282242
unknownphase_2
Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke
NCT02347358
unknown
Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window
NCT01770197
Clinical Trials (3)
Showing 3 of 3 trials
NCT01282242Phase 2
A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
NCT02347358Phase 2
Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke
NCT01770197
Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3